CEP78_HUMAN - dbPTM
CEP78_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CEP78_HUMAN
UniProt AC Q5JTW2
Protein Name Centrosomal protein of 78 kDa
Gene Name CEP78
Organism Homo sapiens (Human).
Sequence Length 689
Subcellular Localization Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole . Cytoplasm, cytoskeleton, cilium basal body . Mainly localizes at the centriolar wall, but also found
Protein Description May be required for efficient PLK4 centrosomal localization and PLK4-induced overduplication of centrioles. [PubMed: 27246242 May play a role in cilium biogenesis]
Protein Sequence MIDSVKLRRDSAADFFSHYEYLCALQNSVPLPAVRACLREGVLDFNADRLRGVDWAPLLSTLKINKDLPLVSIKSFFQPWLGDTGSDMNKFCRSRVPAIRYKDVTFQLCKALKGCLSISSVLKNLELNGLILRERDLTILAKGLNKSASLVHLSLANCPIGDGGLEIICQGIKSSITLKTVNFTGCNLTWQGADHMAKILKYQTMRRHEETWAESLRYRRPDLDCMAGLRRITLNCNTLIGDLGACAFADSLSEDLWLRALDLQQCGLTNEGAKALLEALETNTTLVVLDIRKNPLIDHSMMKAVIKKVLQNGRSAKSEYQWITSPSVKEPSKTAKQKRRTIILGSGHKGKATIRIGLATKKPVSSGRKHSLGKEYYAPAPLPPGVSGFLPWRTAERAKRHRGFPLIKTRDICNQLQQPGFPVTVTVESPSSSEVEEVDDSSESVHEVPEKTSIEQEALQEKLEECLKQLKEERVIRLKVDKRVSELEHENAQLRNINFSLSEALHAQSLTNMILDDEGVLGSIENSFQKFHAFLDLLKDAGLGQLATMAGIDQSDFQLLGHPQMTSTVSNPPKEEKKALEDEKPEPKQNALGQMQNIQFQKITGDARIPLPLDSFPVPVSTPEGLGTSSNNLGVPATEQRQESFEGFIARMCSPSPDATSGTGSQRKEEELSRNSRSSSEKKTKTESH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Ubiquitination--MIDSVKLRRDSAA
--CCCCCCCCCCCHH
39.98-
60PhosphorylationVDWAPLLSTLKINKD
CCCHHHHHHCCCCCC
39.1020860994
61PhosphorylationDWAPLLSTLKINKDL
CCHHHHHHCCCCCCC
31.8520860994
63UbiquitinationAPLLSTLKINKDLPL
HHHHHHCCCCCCCCE
44.30-
66UbiquitinationLSTLKINKDLPLVSI
HHHCCCCCCCCEEEH
65.20-
84PhosphorylationFQPWLGDTGSDMNKF
CCHHHCCCCCHHHHH
36.4728348404
86PhosphorylationPWLGDTGSDMNKFCR
HHHCCCCCHHHHHHH
35.4628348404
90UbiquitinationDTGSDMNKFCRSRVP
CCCCHHHHHHHCCCC
38.92-
102UbiquitinationRVPAIRYKDVTFQLC
CCCCCCHHHHHHHHH
35.55-
138PhosphorylationILRERDLTILAKGLN
EEEHHHHHHHHHCCC
20.45-
147PhosphorylationLAKGLNKSASLVHLS
HHHCCCCCCCHHEEE
23.24-
149PhosphorylationKGLNKSASLVHLSLA
HCCCCCCCHHEEECC
37.71-
174PhosphorylationIICQGIKSSITLKTV
EEECCCCCEEEEEEE
25.67-
175PhosphorylationICQGIKSSITLKTVN
EECCCCCEEEEEEEC
18.00-
198UbiquitinationQGADHMAKILKYQTM
CCHHHHHHHHHHHHH
40.78-
201UbiquitinationDHMAKILKYQTMRRH
HHHHHHHHHHHHHHC
38.49-
211PhosphorylationTMRRHEETWAESLRY
HHHHCHHHHHHHHHH
27.3020873877
215PhosphorylationHEETWAESLRYRRPD
CHHHHHHHHHHCCCC
15.4820873877
300PhosphorylationKNPLIDHSMMKAVIK
CCCCCCHHHHHHHHH
19.4729978859
303UbiquitinationLIDHSMMKAVIKKVL
CCCHHHHHHHHHHHH
30.75-
317 (in isoform 2)Ubiquitination-45.1021890473
317 (in isoform 1)Ubiquitination-45.1021890473
317UbiquitinationLQNGRSAKSEYQWIT
HHHCCCCCCCCEECC
45.1021890473
317 (in isoform 3)Ubiquitination-45.1021890473
318PhosphorylationQNGRSAKSEYQWITS
HHCCCCCCCCEECCC
41.0529396449
320PhosphorylationGRSAKSEYQWITSPS
CCCCCCCCEECCCCC
19.0828796482
324PhosphorylationKSEYQWITSPSVKEP
CCCCEECCCCCCCCC
31.4623663014
325PhosphorylationSEYQWITSPSVKEPS
CCCEECCCCCCCCCC
13.1725159151
327PhosphorylationYQWITSPSVKEPSKT
CEECCCCCCCCCCCC
45.6628176443
329UbiquitinationWITSPSVKEPSKTAK
ECCCCCCCCCCCCCC
69.14-
329 (in isoform 1)Ubiquitination-69.1421890473
329 (in isoform 3)Ubiquitination-69.1421890473
329 (in isoform 2)Ubiquitination-69.1421890473
332PhosphorylationSPSVKEPSKTAKQKR
CCCCCCCCCCCCCCC
43.6728450419
334PhosphorylationSVKEPSKTAKQKRRT
CCCCCCCCCCCCCCE
43.3423312004
336UbiquitinationKEPSKTAKQKRRTII
CCCCCCCCCCCCEEE
62.68-
341PhosphorylationTAKQKRRTIILGSGH
CCCCCCCEEEECCCC
19.1924173317
346PhosphorylationRRTIILGSGHKGKAT
CCEEEECCCCCCCEE
33.99-
349UbiquitinationIILGSGHKGKATIRI
EEECCCCCCCEEEEE
66.68-
351UbiquitinationLGSGHKGKATIRIGL
ECCCCCCCEEEEEEE
47.35-
361UbiquitinationIRIGLATKKPVSSGR
EEEEEECCCCCCCCC
49.85-
361AcetylationIRIGLATKKPVSSGR
EEEEEECCCCCCCCC
49.8525953088
361 (in isoform 2)Phosphorylation-49.85-
361 (in isoform 5)Phosphorylation-49.85-
371PhosphorylationVSSGRKHSLGKEYYA
CCCCCCCCCCCEEEE
41.6824719451
372PhosphorylationSSGRKHSLGKEYYAP
CCCCCCCCCCEEEEC
13.05-
374 (in isoform 1)Ubiquitination-48.0821890473
374 (in isoform 3)Ubiquitination-48.0821890473
374UbiquitinationGRKHSLGKEYYAPAP
CCCCCCCCEEEECCC
48.082189047
375UbiquitinationRKHSLGKEYYAPAPL
CCCCCCCEEEECCCC
41.81-
375 (in isoform 2)Ubiquitination-41.8121890473
376PhosphorylationKHSLGKEYYAPAPLP
CCCCCCEEEECCCCC
14.38-
377PhosphorylationHSLGKEYYAPAPLPP
CCCCCEEEECCCCCC
13.75-
408UbiquitinationHRGFPLIKTRDICNQ
HCCCCCEEHHHHHHH
45.23-
409UbiquitinationRGFPLIKTRDICNQL
CCCCCEEHHHHHHHC
26.95-
424PhosphorylationQQPGFPVTVTVESPS
CCCCCCEEEEEECCC
15.6523898821
431PhosphorylationTVTVESPSSSEVEEV
EEEEECCCCCCCEEC
56.6323898821
432PhosphorylationVTVESPSSSEVEEVD
EEEECCCCCCCEECC
33.6222468782
453PhosphorylationHEVPEKTSIEQEALQ
CCCCCCCCHHHHHHH
34.8825627689
463UbiquitinationQEALQEKLEECLKQL
HHHHHHHHHHHHHHH
7.06-
469UbiquitinationKLEECLKQLKEERVI
HHHHHHHHHHHHHHH
44.83-
485PhosphorylationLKVDKRVSELEHENA
HCCCHHHHHHHHHCH
40.2628450419
486PhosphorylationKVDKRVSELEHENAQ
CCCHHHHHHHHHCHH
56.15-
579UbiquitinationPPKEEKKALEDEKPE
CCHHHHHHHCCCCCC
27.53-
579 (in isoform 2)Ubiquitination-27.53-
585 (in isoform 2)Ubiquitination-62.16-
585UbiquitinationKALEDEKPEPKQNAL
HHHCCCCCCHHCCHH
62.16-
602UbiquitinationMQNIQFQKITGDARI
HHCEEEEECCCCCCC
43.45-
615O-linked_GlycosylationRIPLPLDSFPVPVST
CCCCCCCCCCCCCCC
38.8530620550
619 (in isoform 2)Ubiquitination-17.99-
621PhosphorylationDSFPVPVSTPEGLGT
CCCCCCCCCCCCCCC
31.9828348404
622O-linked_GlycosylationSFPVPVSTPEGLGTS
CCCCCCCCCCCCCCC
26.1230620550
622PhosphorylationSFPVPVSTPEGLGTS
CCCCCCCCCCCCCCC
26.1224173317
628PhosphorylationSTPEGLGTSSNNLGV
CCCCCCCCCCCCCCC
33.7428348404
629PhosphorylationTPEGLGTSSNNLGVP
CCCCCCCCCCCCCCC
29.3028348404
630O-linked_GlycosylationPEGLGTSSNNLGVPA
CCCCCCCCCCCCCCC
29.5830620550
630PhosphorylationPEGLGTSSNNLGVPA
CCCCCCCCCCCCCCC
29.5828348404
644PhosphorylationATEQRQESFEGFIAR
CHHHHHHHHHHHHHH
21.9125850435
652SulfoxidationFEGFIARMCSPSPDA
HHHHHHHHCCCCCCC
1.6421406390
654PhosphorylationGFIARMCSPSPDATS
HHHHHHCCCCCCCCC
21.0429255136
656PhosphorylationIARMCSPSPDATSGT
HHHHCCCCCCCCCCC
21.0829255136
660PhosphorylationCSPSPDATSGTGSQR
CCCCCCCCCCCCHHH
34.7629255136
661PhosphorylationSPSPDATSGTGSQRK
CCCCCCCCCCCHHHH
35.7629255136
663PhosphorylationSPDATSGTGSQRKEE
CCCCCCCCCHHHHHH
33.1729255136
665PhosphorylationDATSGTGSQRKEEEL
CCCCCCCHHHHHHHH
27.0129255136
671PhosphorylationGSQRKEEELSRNSRS
CHHHHHHHHHHCCCC
53.81-
673PhosphorylationQRKEEELSRNSRSSS
HHHHHHHHHCCCCCC
32.47-
682UbiquitinationNSRSSSEKKTKTESH
CCCCCCCCCCCCCCC
68.63-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CEP78_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CEP78_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CEP78_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CEP76_HUMANCEP76physical
28242748
CP110_HUMANCCP110physical
28242748
DCAF1_HUMANVPRBPphysical
28242748
DDB1_HUMANDDB1physical
28242748
UBR5_HUMANUBR5physical
28242748
DYRK2_HUMANDYRK2physical
28242748

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CEP78_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-325, AND MASSSPECTROMETRY.

TOP